latent GDF-8

latent GDF-8

latent GDF-8 분자 정보

Molecule Name
Growth/differentiation factor 8
분자 별명
latent GDF-8
Drug Development Progress
임상 약물 수6
시판 약물 수0
최고 연구 개발 단계NDA/BLA
표적 별명
MSTN,GDF-8,GDF8,Growth Differentiation Factor 8,MSLHP,Myostatin,Growth/Differentiation Factor 8
분자 배경
Growth differentiation factor 8 (GDF8), also known as myostatin, is a unique member of the transforming growth factor-β superfamily that is expressed in human granulosa cells and has important roles in regulating a variety of ovarian functions. GDF8 acts as a negative regulator of skeletal muscle growth and differentiation. In addition to the expression in the musculoskeletal system, GDF8 is also expressed in various tissues, including the reproductive system.

제품 문의

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Talditercept alfaRO-7239361; BMS-986089; RG-6206; BHV-2000Phase 3 ClinicalBristol-Myers Squibb Company
Muscular Dystrophy, Duchenne; Neuromuscular Diseases; Muscular Atrophy, Spinal
상세
RO-7204239GYM-329; RO-7204239; RG-6237; RG-70240Phase 3 ClinicalF. Hoffmann-La Roche Ltd, Chugai Pharmaceutical Co Ltd
Muscular Dystrophy, Facioscapulohumeral; Muscular Atrophy, Spinal
상세
TrevogrumabREGN-1033; REGN1033; SAR-391786; GDF8Phase 2 ClinicalRegeneron Pharmaceuticals Inc
Myositis, Inclusion Body; Obesity; Sarcopenia
상세
AAV1-FS344AAV1-Follistatin; AAV1-FS344Phase 2 ClinicalNationwide Children'S Hospital
Becker muscular dystrophy; Myositis, Inclusion Body; Muscular Dystrophy, Duchenne
상세
KER-065KER-065; RKER-065Phase 1 ClinicalKeros Therapeutics Inc
Neuromuscular Diseases; Obesity
상세
HS135HS-135Phase 1 Clinical35Pharma Inc
Hypertension, Pulmonary; Heart Failure, Diastolic; Pulmonary Arterial Hypertension
상세